MGRX

0.23% 0.0012

Handel nachbörslich: .51 -0.0244 -4.57%

Mangoceuticals Inc (MGRX)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Mangoceuticals Inc Stock (MGRX) Company Profile

Mangoceuticals Inc

Healthcare (1080)

(833) 626-4679

15110 DALLAS PKWY, SUITE 600, DALLAS

Nächster Verdiensttermin

Neueste SEC-Einreichungen

MGRX's Discussions on Twitter

Compare MGRX vs VEEV, BTSG, TEM, HQY, TXG

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MGRX Mangoceuticals Inc	0.5344	9.15M	414.60K	-19.21M	-4.89M	-1.6207
VEEV Veeva Systems Inc	243.75	39.23B	3.32B	941.65M	1.64B	5.6161
BTSG Brightspring Health Services Inc	61.71	11.81B	13.65B	169.86M	412.12M	1.0758
TEM Tempus Ai Inc	52.10	9.85B	1.36B	-302.91M	-219.93M	-1.7182
HQY Healthequity Inc	104.73	8.82B	1.34B	230.70M	440.96M	2.6695
TXG 10 X Genomics Inc	56.09	7.52B	638.78M	-22.66M	122.18M	-0.1744

Mangoceuticals Inc Aktie (MGRX) Neueste Nachrichten

Finanzdaten der Mangoceuticals Inc-Aktie (MGRX)

Mangoceuticals Inc (MGRX)

Mangoceuticals Inc Stock (MGRX) Company Profile

Compare MGRX vs VEEV, BTSG, TEM, HQY, TXG

Mangoceuticals Inc Aktie (MGRX) Neueste Nachrichten

MANGOCEUTICALS, INC. Q2 2026: Revenue $68.76K, EPS $(0.09) — 10-Q Summary - TradingView

Mangoceuticals (MGRX) Q2 2026 loss shrinks while cash and revenue fall - Stock Titan

Mangoceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

12 Consumer Staples Stocks Moving In Thursday's After-Market Session - Benzinga

Nuclea’s planned Moltex deal could add 80 nuclear patents - Stock Titan

Why is Mangoceuticals stock surging today? - Investing.com India

On Thursday, there are stocks with unusual volume. Let's take a look. - ChartMill

Why is Mangoceuticals stock surging today? By Investing.com - Investing.com South Africa

Mangoceuticals’ Merger Partner, Nuclea Energy Inc., Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure - The Manila Times

Mangoceuticals’ Merger Partner, Nuclea Energy Inc., Signs - globenewswire.com

Mangoceuticals (MGRX) merger partner Nuclea inks Utah nuclear test reactor MOU - Stock Titan

Mangoceuticals (MGRX) Stock Jumps Over 49% After Hours: Here's Why - Benzinga

Mangoceuticals merger partner Nuclea signs MOU with New Mining on modular reactor power for data centers - Bitget

Mangoceuticals Wins Nasdaq Extension Amid Nuclea Deal Progress - The Globe and Mail

Wondering what's happening in today's after-hours session? - ChartMill

Mangoceuticals’ Merger Partner, Nuclea Energy (“Nuclea”), Executes MOU with Utah Office of Energy Development - Yahoo Finance

Mangoceuticals (NASDAQ: MGRX) wins more time on Nasdaq rules, advances Nuclea deal - Stock Titan

Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination - The Manila Times

Mangoceuticals Inc. (MGRX) Slides 15% to $0.45 as Selling Pressure IntensifiesSmart Money Flow Stocks - dars.gov.et

$Mangoceuticals (MGRX.US)$ - moomoo.com

Mangoceuticals, Inc. Common Stock (NASDAQ: MGRX) Stock Price, News & Analysis - Kalkine

Microcaps MGRX, PRSO, IGC, KUST In the News to Watch - openPR.com

That’s quite fortunate! - Moomoo

$Mangoceuticals (MGRX.US)$ wow finally CB ⬆️ [Grin][Drool][Cool Guy][Angry][Tongue] - moomoo.com

$Mangoceuticals (MGRX.US)$ sold a tad early. but definitely looking for another entry! - Moomoo

Mangoceuticals (NASDAQ:MGRX) Shares Surge Almost Threefold Following Nuclea Agreement; Existing Shareholders Retain 4% - TechStock²

Form 4 Mangoceuticals Inc For: 30 July By Investing.com - Investing.com Canada

Nuclea Energy to go public via merger with Mangoceuticals By Investing.com - Investing.com Nigeria

Nuclea Energy Enters Definitive Business Combination Agreement with Mangoceuticals, Establishing a Path to a Nasdaq Public Listing to Advance the Morpheus Microreactor - TMX Newsfile

Nuclea Energy Inc: Nuclea Energy Enters Definitive Business Combination Agreement with Mangoceuticals, Establishing a Path to a Nasdaq Public Listing to Advance the Morpheus Microreactor - FinanzNachrichten.de

Mangoceuticals agrees to merge with nuclear microreactor developer - Investing.com Nigeria

Mangoceuticals agrees to merge with nuclear microreactor developer By Investing.com - Investing.com Canada

Jacob D. Cohen to Leave CEO Role at Mangoceuticals, Becomes President in Consulting Role - TradingView

Mangoceuticals to merge with Nuclea Energy to a... - pluang.com

Mangoceuticals Inc (MGRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Mangoceuticals Inc (MGRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Mangoceuticals Inc (MGRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Mangoceuticals Inc (MGRX) Cash Flow - TradingKey

Mangoceuticals Inc (MGRX) Income Statement - TradingKey

MGRX|Mangoceuticals Inc|Price:0.542|Chg%:-0.001 - TradingKey

MGRX|Mangoceuticals Inc|Price:0.521|Chg%:-0.037 - TradingKey

Mangoceuticals (MGRX) Slips 6.58% as Stock Tests Critical Support LevelsDaily Profile - dars.gov.et

Mangoceuticals Inc (MGRX) Institutional Confidence - TradingKey

Mangoceuticals, Inc. Revenue Breakdown – NASDAQ:MGRX - TradingView

Mangoceuticals Inc (MGRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Mangoceuticals stock doubles after Texas lawsuit - MSN

MGRX Q3 2025 Earnings: Net Loss Widens as Pre-Revenue Biotech Focuses on Clinical PipelineNet Profit Margin - po-news-eg.net

Price to sales forward of Mangoceuticals, Inc. – BOATS:MGRX - TradingView

Mangoceuticals (MGRX) Slips 2.46% as Stock Approaches Key Support at $0.34Zero Gamma Level - dars.gov.et

MGRX Q3 2025 Earnings: Wider Loss Reported as Stock Gains Despite Opaque Financial DisclosureBasic EPS Analysis - dars.gov.et

Price to earnings forward of Mangoceuticals, Inc. – NASDAQ:MGRX - TradingView

Finanzdaten der Mangoceuticals Inc-Aktie (MGRX)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie MGRX